LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Vitamin E Blended With Knee Implant
Large Joints and Extremities

Vitamin E Blended With Knee Implant

August 22, 2012 1 min read Premium comments

Advertisement

Vitamin E Blended With Knee Implant
Source: Wikimedia Commons and Tamorian
Secondary

James Helgager, M.D., an orthopedic surgeon with the Tri-City Medical Center in Oceanside, California, and Medical Director of Joint Replacement for the Orthopaedic & Spine Institute at Tri-City Medical Center, implanted the first vitamin E Total Knee Replacement in San Diego County.

The E-plus substance, manufactured by Vista-based DJO Surgical, is a polyethylene blended with vitamin E, an anti-oxidant that was created for the 3DKnee. The manufacturers say the addition of the vitamin improves strength, stability and flexion in the implant.

Company officials note that polyethylene wear continues to be a weak point in total knee replacement. They claim that vitamin E improves the material’s tensile strength while preventing polyethylene degenerating oxidation, helping the material hold up to the expectations of today’s active patient. E-plus is the first blended vitamin e polyethylene, meaning that the vitamin E is blended into the resin and is homogeneous throughout the insert component.

The 3DKnee Data Driven Design is based on over a decade of research into total knee kinematics and over 30, 000 have been implanted world-wide, according to company officials. “The cause of Total Knee Replacement failure is polyethylene wear and DJO’s E-plus polyethylene bearing surface is very promising in addressing this issue, ” said Helgager, long-term studies will prove its longevity and performance benefits to the patient.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy